A multicenter, open-label trial to assess cognitive and psychomotor performance as surrogate parameters for driving ability under stable long term treatment with tapentadol hydrochloride prolonged-release tablets in subjects with chronic low back pain or osteoarthritis of the knee.
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2014
At a glance
- Drugs Tapentadol (Primary)
- Indications Back pain; Musculoskeletal pain
- Focus Adverse reactions
- 21 Jun 2011 New trial record